Literature DB >> 10047779

Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4.

M Bryans1, M C Valenzano, T D Stamato.   

Abstract

XR-1 is a CHO mutant cell line defective in double strand break repair and V(D)J recombination. These defects are due to a deletion of the XRCC4 gene which encodes a 38-kDa nuclear phosphoprotein. Recent studies have shown that XRCC4 interacts with and enhances the activity of DNA ligase IV in vitro. In this study we investigate the effect of the absence of XRCC4 on the level of DNA ligase IV in XR-1 cells. Western blot analysis indicates that levels of DNA ligase IV protein are almost undetectable in these cells, however, introduction of the XRCC4 cDNA into XR-1 resulted in a return to wild type levels of the protein. Furthermore, analysis of DNA ligase IV mRNA showed equivalent levels in both XR-1 and XRCC4 transfected XR-1 indicating that the altered level of DNA ligase IV is not due to a change in the expression of the gene. These data strongly suggest that an important function of XRCC4 is to stabilize the DNA ligase IV protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10047779     DOI: 10.1016/s0921-8777(98)00063-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  72 in total

1.  Ku recruits the XRCC4-ligase IV complex to DNA ends.

Authors:  S A Nick McElhinny; C M Snowden; J McCarville; D A Ramsden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Mitochondrial DNA ligase III function is independent of Xrcc1.

Authors:  U Lakshmipathy; C Campbell
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 3.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

4.  Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells.

Authors:  A J Pierce; P Hu; M Han; N Ellis; M Jasin
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

5.  An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells.

Authors:  Fabien Delacôte; Mingguang Han; Thomas D Stamato; Maria Jasin; Bernard S Lopez
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

6.  Delineation of the Xrcc4-interacting region in the globular head domain of cernunnos/XLF.

Authors:  Laurent Malivert; Virginie Ropars; Marcela Nunez; Pascal Drevet; Simona Miron; Guilhem Faure; Raphael Guerois; Jean-Paul Mornon; Patrick Revy; Jean-Baptiste Charbonnier; Isabelle Callebaut; Jean-Pierre de Villartay
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

7.  Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4.

Authors:  Peï-Yu Wu; Philippe Frit; SriLakshmi Meesala; Stéphanie Dauvillier; Mauro Modesti; Sara N Andres; Ying Huang; JoAnn Sekiguchi; Patrick Calsou; Bernard Salles; Murray S Junop
Journal:  Mol Cell Biol       Date:  2009-03-30       Impact factor: 4.272

8.  DNA-PK-dependent binding of DNA ends to plasmids containing nuclear matrix attachment region DNA sequences: evidence for assembly of a repair complex.

Authors:  Stanley K Mauldin; Robert C Getts; Wenjing Liu; Thomas D Stamato
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

9.  E1B 55k-independent dissociation of the DNA ligase IV/XRCC4 complex by E4 34k during adenovirus infection.

Authors:  Sumithra Jayaram; Timra Gilson; Elana S Ehrlich; Xiao-Fang Yu; Gary Ketner; Les Hanakahi
Journal:  Virology       Date:  2008-10-25       Impact factor: 3.616

10.  Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.

Authors:  Christine Anne Koch; Roger Agyei; Sarah Galicia; Pavel Metalnikov; Paul O'Donnell; Andrei Starostine; Michael Weinfeld; Daniel Durocher
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.